Simvastatin Increases the Ability of Roflumilast N-oxide to Inhibit Cigarette Smoke-Induced Epithelial to Mesenchymal Transition in Well-differentiated Human Bronchial Epithelial Cells in vitro

References

• Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004; 364:613–620.
   PubMed Web of Science ®Google Scholar
• Hogg JC, McDonough JE, Suzuki M. Small airway obstruction in COPD: New insights based on micro-ct imaging and mri imaging. Chest 2013; 143:1436–1443.
   PubMed Web of Science ®Google Scholar
• Burgel PR, Bourdin A, Chanez P, Chabot F, Chaouat A, Chinet T, de Blic J, Devillier P, Deschildre A, Didier A, Garcia G, Jebrak G, Laurent F, Morel H, Perez T, Pilette C, Roche N, Tillie-Leblond I, Verbanck S, Dusser D. Update on the roles of distal airways in COPD. Eur Respir Rev 2011; 20:7–22.
   PubMedGoogle Scholar
• Milara J, Peiro T, Serrano A, Cortijo J. Epithelial to mesenchymal transition is increased in patients with COPD and induced by cigarette smoke. Thorax 2013; 68:410–420.
   PubMed Web of Science ®Google Scholar
• Matera MG, Calzetta L, Segreti A, Cazzola M. Emerging drugs for chronic obstructive pulmonary disease. Expert Opin Emerg Drugs 2012; 17:61–82.
   PubMed Web of Science ®Google Scholar
• Dunkern TR, Feurstein D, Rossi GA, Sabatini F, Hatzelmann A. Inhibition of tgf-beta induced lung fibroblast to myofibroblast conversion by phosphodiesterase inhibiting drugs and activators of soluble guanylyl cyclase. Eur J Pharmacol 2007; 572:12–22.
   PubMed Web of Science ®Google Scholar
• Kolosionek E, Savai R, Ghofrani HA, Weissmann N, Guenther A, Grimminger F, Seeger W, Banat GA, Schermuly RT, Pullamsetti SS. Expression and activity of phosphodiesterase isoforms during epithelial mesenchymal transition: The role of phosphodiesterase 4. Mol Biol Cell 2009; 20:4751–4765.
   PubMed Web of Science ®Google Scholar
• Selige J, Hatzelmann A, Dunkern T. The differential impact of pde4 subtypes in human lung fibroblasts on cytokine-induced proliferation and myofibroblast conversion. J Cell Physiol 2011; 226:1970–1980.
   PubMed Web of Science ®Google Scholar
• Young RP, Hopkins R, Eaton TE. Pharmacological actions of statins: Potential utility in COPD. Eur Respir Rev 2009; 18:222–232.
   PubMedGoogle Scholar
• Lee JH, Lee DS, Kim EK, Choe KH, Oh YM, Shim TS, Kim SE, Lee YS, Lee SD. Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs. Am J Respir Crit Care Med 2005; 172:987–993.
   PubMed Web of Science ®Google Scholar
• Wan WY, Morris A, Kinnear G, Pearce W, Mok J, Wyss D, Stevenson CS. Pharmacological characterisation of anti-inflammatory compounds in acute and chronic mouse models of cigarette smoke-induced inflammation. Respir Res 2010; 11:126.
   PubMed Web of Science ®Google Scholar
• Wright JL, Zhou S, Preobrazhenska O, Marshall C, Sin DD, Laher I, Golbidi S, Churg AM. Statin reverses smoke-induced pulmonary hypertension and prevents emphysema but not airway remodeling. Am J Respir Crit Care Med 2011; 183:50–58.
   PubMed Web of Science ®Google Scholar
• Davis BB, Zeki AA, Bratt JM, Wang L, Filosto S, Walby WF, Kenyon NJ, Goldkorn T, Schelegle ES, Pinkerton KE. Simvastatin inhibits smoke-induced airway epithelial injury: Implications for COPD therapy. Eur Respir J 2013; 42(2):350–361.
   PubMed Web of Science ®Google Scholar
• Grommes J, Vijayan S, Drechsler M, Hartwig H, Morgelin M, Dembinski R, Jacobs M, Koeppel TA, Binnebosel M, Weber C, Soehnlein O. Simvastatin reduces endotoxin-induced acute lung injury by decreasing neutrophil recruitment and radical formation. PLoS One 2012; 7:e38917.
   PubMed Web of Science ®Google Scholar
• Shyamsundar M, McKeown ST, O'Kane CM, Craig TR, Brown V, Thickett DR, Matthay MA, Taggart CC, Backman JT, Elborn JS, McAuley DF. Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers. Am J Respir Crit Care Med 2009; 179:1107–1114.
   PubMed Web of Science ®Google Scholar
• Janda S, Park K, FitzGerald JM, Etminan M, Swiston J. Statins in COPD: A systematic review. Chest 2009; 136:734–743.
   PubMed Web of Science ®Google Scholar
• Johnson BA, Iacono AT, Zeevi A, McCurry KR, Duncan SR. Statin use is associated with improved function and survival of lung allografts. Am J Respir Crit Care Med 2003; 167:1271–1278.
   PubMed Web of Science ®Google Scholar
• Patel S, Mason RM, Suzuki J, Imaizumi A, Kamimura T, Zhang Z. Inhibitory effect of statins on renal epithelial-to-mesenchymal transition. Am J Nephrol 2006; 26:381–387.
   PubMed Web of Science ®Google Scholar
• Yang T, Chen M, Sun T. Simvastatin attenuates tgf-beta1-induced epithelial-mesenchymal transition in human alveolar epithelial cells. Cell Physiol Biochem 2013; 31:863–874.
   PubMed Web of Science ®Google Scholar
• Milara J, Peiro T, Serrano A, Guijarro R, Zaragoza C, Tenor H, Cortijo J. Roflumilast n-oxide inhibits bronchial epithelial to mesenchymal transition induced by cigarette smoke in smokers with COPD. Pulm Pharmacol Ther 2014, in press.
   PubMed Web of Science ®Google Scholar
• Milara J, Armengot M, Banuls P, Tenor H, Beume R, Artigues E, Cortijo J. Roflumilast n-oxide, a pde4 inhibitor, improves cilia motility and ciliated human bronchial epithelial cells compromised by cigarette smoke in vitro. Br J Pharmacol 2012; 166:2243–2262.
   PubMed Web of Science ®Google Scholar
• Ortiz JL, Milara J, Juan G, Montesinos JL, Mata M, Ramon M, Morcillo E, Cortijo J. Direct effect of cigarette smoke on human pulmonary artery tension. Pulm Pharmacol Ther 2010; 23:222–228.
   PubMed Web of Science ®Google Scholar
• Bethke TD, Bohmer GM, Hermann R, Hauns B, Fux R, Morike K, David M, Knoerzer D, Wurst W, Gleiter CH. Dose-proportional intraindividual single- and repeated-dose pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor. J Clin Pharmacol 2007; 47:26–36.
   PubMed Web of Science ®Google Scholar
• Yano T, Yamazaki Y, Adachi M, Okawa K, Fort P, Uji M, Tsukita S. Tara up-regulates e-cadherin transcription by binding to the trio rhogef and inhibiting rac signaling. J Cell Biol 2011; 193:319–332.
   Google Scholar
• Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 2000; 275:36803–36810.
   PubMed Web of Science ®Google Scholar
• Trayner ID, Rayner AP, Freeman GE, Farzaneh F. Quantitative multiwell myeloid differentiation assay using dichlorodihydrofluorescein diacetate (h2dcf-da) or dihydrorhodamine 123 (h2r123). J Immunol Meth 1995; 186:275–284.
   PubMed Web of Science ®Google Scholar
• Dasari V, Gallup M, Lemjabbar H, Maltseva I, McNamara N. Epithelial-mesenchymal transition in lung cancer: Is tobacco the “smoking gun”? Am J Respir Cell Mol Biol 2006; 35:3–9.
   PubMed Web of Science ®Google Scholar
• Wang Q, Wang Y, Zhang Y, Xiao W. The role of uPAR in epithelial-mesenchymal transition in small airway epithelium of patients with chronic obstructive pulmonary disease. Respir Res 2013; 14:67.
   PubMed Web of Science ®Google Scholar
• Gorowiec MR, Borthwick LA, Parker SM, Kirby JA, Saretzki GC, Fisher AJ. Free radical generation induces epithelial-to-mesenchymal transition in lung epithelium via a tgf-beta1-dependent mechanism. Free Radic Biol Med 2012; 52:1024–1032.
   PubMed Web of Science ®Google Scholar
• Zhang L, Gallup M, Zlock L, Finkbeiner WE, McNamara NA. Rac1 and cdc42 differentially modulate cigarette smoke-induced airway cell migration through p120-catenin-dependent and independent pathways. Am J Pathol 2013; 182(6):1982–1995.
   Google Scholar
• Bouquier N, Vignal E, Charrasse S, Weill M, Schmidt S, Leonetti JP, Blangy A, Fort P. A cell active chemical gef inhibitor selectively targets the trio/rhog/rac1 signaling pathway. Chem Biol 2009; 16:657–666.
   PubMedGoogle Scholar
• Shen HJ, Sun YH, Zhang SJ, Jiang JX, Dong XW, Jia YL, Shen J, Guan Y, Zhang LH, Li FF, Lin XX, Wu XM, Xie QM, Yan XF. Cigarette smoke-induced alveolar epithelial-mesenchymal transition is mediated by rac1 activation. Biochim Biophys Acta 2014; 1840:1838–1849.
   PubMed Web of Science ®Google Scholar
• Marwick JA, Caramori G, Stevenson CS, Casolari P, Jazrawi E, Barnes PJ, Ito K, Adcock IM, Kirkham PA, Papi A. Inhibition of pi3kdelta restores glucocorticoid function in smoking-induced airway inflammation in mice. Am J Respir Crit Care Med 2009; 179:542–548.
   PubMed Web of Science ®Google Scholar
• Milara J, Lluch J, Almudever P, Freire J, Xiaozhong Q, Cortijo J. Roflumilast n-oxide reverses corticosteroid resistance in neutrophils from patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol 2014; 134(2):314–322.
   PubMed Web of Science ®Google Scholar
• To Y, Ito K, Kizawa Y, Failla M, Ito M, Kusama T, Elliott WM, Hogg JC, Adcock IM, Barnes PJ. Targeting phosphoinositide-3-kinase-delta with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 182:897–904.
   PubMed Web of Science ®Google Scholar
• Tian D, Zhu M, Li J, Ma Y, Wu R. Cigarette smoke extract induces activation of beta-catenin/tcf signaling through inhibiting gsk3beta in human alveolar epithelial cell line. Toxicol Lett 2009; 187:58–62.
   Google Scholar
• Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33:1165–1185.
   PubMed Web of Science ®Google Scholar
• Young RP, Hopkins RJ. Statins and small airways disease in COPD. Am J Respir Cell Mol Biol 2013; 49:501.
   PubMed Web of Science ®Google Scholar
• Criner GJ, Connett JE, Aaron SD, Albert RK, Bailey WC, Casaburi R, Cooper JA Jr., Curtis JL, Dransfield MT, Han MK, Make B, Marchetti N, Martinez FJ, Niewoehner DE, Scanlon PD, Sciurba FC, Scharf SM, Sin DD, Voelker H, Washko GR, Woodruff PG, Lazarus SC. Simvastatin for the prevention of exacerbations in moderate-to-severe COPD. N Engl J Med 2014; 370:2201–2210.
   PubMed Web of Science ®Google Scholar
• Muzaffar S, Shukla N, Bond M, Sala-Newby G, Angelini GD, Newby AC, Jeremy JY. Acute inhibition of superoxide formation and rac1 activation by nitric oxide and iloprost in human vascular smooth muscle cells in response to the thromboxane a2 analogue, u46619. Prostaglandins Leukot Essent Fatty Acids 2008; 78:247–255.
   PubMed Web of Science ®Google Scholar
• Muzaffar S, Shukla N, Angelini GD, Jeremy JY. Roflumilast N-oxide inhibits NADPH oxidase expression and activity in human pulmonary artery smooth muscle cells. Proc Br Pharmacol Soc 2008; 6:027P.
   Google Scholar
• Mayeenuddin LH, Garrison JC. Phosphorylation of p-rex1 by the cyclic amp-dependent protein kinase inhibits the phosphatidylinositiol (3,4,5)-trisphosphate and gbetagamma-mediated regulation of its activity. J Biol Chem 2006; 281:1921–1928.
   PubMed Web of Science ®Google Scholar
• Birukova AA, Burdette D, Moldobaeva N, Xing J, Fu P, Birukov KG. Rac gtpase is a hub for protein kinase a and epac signaling in endothelial barrier protection by camp. Microvasc Res 2010; 79:128–138.
   Google Scholar